Literature DB >> 30722966

The Management of Colorectal Cancer Liver Metastases: The Radiation Oncology Viewpoint.

Aisling Barry1, Rebecca Wong2, Laura A Dawson2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30722966     DOI: 10.1016/j.ijrobp.2018.10.010

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  4 in total

1.  Conversion therapy combined with individualized surgical treatment strategy improves survival in patients with colorectal cancer liver metastases.

Authors:  Rui Ma; Tao Li
Journal:  Int J Clin Exp Pathol       Date:  2021-03-01

2.  Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy.

Authors:  Ciro Franzese; Tiziana Comito; Davide Franceschini; Mauro Loi; Elena Clerici; Pierina Navarria; Fiorenza De Rose; Lucia Di Brina; Pietro Mancosu; Giacomo Reggiori; Stefano Tomatis; Marta Scorsetti
Journal:  J Cancer Res Clin Oncol       Date:  2020-02-13       Impact factor: 4.553

Review 3.  MR-Guided Radiotherapy for Liver Malignancies.

Authors:  Luca Boldrini; Stefanie Corradini; Cihan Gani; Lauren Henke; Ali Hosni; Angela Romano; Laura Dawson
Journal:  Front Oncol       Date:  2021-04-01       Impact factor: 6.244

4.  mFOLFOXIRI with or without bevacizumab for conversion therapy of RAS/BRAF/PIK3CA mutant unresectable colorectal liver metastases: the FORBES non-randomized phase II trial.

Authors:  Cailu Shen; Huabin Hu; Yue Cai; Jiayu Ling; Jianwei Zhang; Zehua Wu; Xiaoyu Xie; Meijin Huang; Hui Wang; Liang Kang; Ping Lan; Xiaojian Wu; Guangjian Liu; Yunle Wan; Zhiyang Zhou; Yan Huang; Fangqian Li; Huaiming Wang; Tenghui Ma; Shuangling Luo; Yonghua Cai; Lishuo Shi; Yanhong Deng
Journal:  Ann Transl Med       Date:  2022-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.